Welcome to our dedicated page for Cartesian Growth Iii SEC filings (Ticker: CGCT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cartesian Growth Corporation III (NASDAQ: CGCT) files reports and transaction documents with the U.S. Securities and Exchange Commission that detail its activities as a special purpose acquisition company and its proposed Business Combination with Factorial Inc. Through this SEC filings page, readers can review current reports on Form 8-K, registration statements, and proxy materials that describe the structure, terms, and conditions of the transaction.
In a Form 8-K dated December 17, 2025, Cartesian III reported entry into a Business Combination Agreement with Factorial and a merger subsidiary. That filing outlines the planned domestication from the Cayman Islands to Delaware, the conversion of existing Cartesian III shares into New Factorial Series A Common Stock, the renaming of the post-closing entity to Factorial Holdings, Inc., and the subsequent merger in which Factorial becomes a wholly owned subsidiary. It also summarizes shareholder redemption rights, warrant treatment, governance arrangements, and key closing conditions, including Hart-Scott-Rodino clearance and Nasdaq listing approval.
On this page, users can access such 8-Ks along with other periodic and transactional filings to understand how CGCT’s units, Class A ordinary shares, and warrants are treated in the proposed combination. Filings also describe Cartesian III’s status as an emerging growth company and its affiliation with Cartesian Capital Group, LLC.
Stock Titan enhances access to these documents by pairing real-time updates from the SEC’s EDGAR system with AI-powered summaries that highlight the main points of lengthy agreements and disclosures. This helps readers quickly identify sections dealing with shareholder redemptions, exchange ratios, governance terms, and other elements that are central to evaluating Cartesian III’s Business Combination with Factorial.
Cartesian Growth Corporation III (CGCT) filed its Q3 2025 10-Q, reflecting SPAC-stage activity with interest income driving results. The company reported net income of $2,764,627 for the quarter, primarily from $2,901,973 of interest earned on investments in its Trust Account, offset by $137,346 in general and administrative costs.
Following its May 2025 IPO of 27,600,000 units at $10.00, the Trust Account held $280,669,717 as of September 30, 2025, invested in U.S. Treasury-focused mutual funds. Transaction costs totaled $18,821,468, including a $13,140,000 deferred underwriting fee. The company sold 6,800,000 private placement warrants for $6,800,000 and has 20,600,000 total warrants outstanding.
Cash was $660,638 outside the Trust, with operating cash use of $468,024 year-to-date. The company remains in its pre-combination phase and discloses substantial doubt about its ability to continue as a going concern absent a timely business combination within the stated completion window. As of November 14, 2025, shares outstanding were 27,600,000 Class A and 6,900,000 Class B.